Enzo Biochem Company Profile (NYSE:ENZ)

About Enzo Biochem

Enzo Biochem logoEnzo Biochem, Inc. (Enzo) is an integrated life science and biotechnology company, which is engaged in the research, development, manufacturing and marketing of diagnostic and research products based on genetic engineering, biotechnology and molecular biology. These products are designed for the diagnosis of and/or screening for infectious diseases, cancers, genetic defects and other medically pertinent diagnostic information and are distributed in the United States and internationally. The Company operates through three segments: Enzo Life Sciences, Enzo Clinical Labs and Enzo Therapeutics. Enzo Life Sciences segment manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers around the world. Enzo Clinical Labs segment provides diagnostic services to the healthcare community. Enzo Therapeutics segment conducts research and development activities for therapeutic drug candidates.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: ENZ
  • CUSIP:
Key Metrics:
  • Previous Close: $5.13
  • 50 Day Moving Average: $5.79
  • 200 Day Moving Average: $5.62
  • 52-Week Range: $2.95 - $7.00
  • Trailing P/E Ratio: 13.43
  • Foreward P/E Ratio: -28.50
  • P/E Growth: 0.00
  • Market Cap: $237.33M
  • Outstanding Shares: 46,264,000
  • Beta: 1.5
Profitability:
  • Net Margins: 17.27%
  • Return on Equity: -20.77%
  • Return on Assets: -13.64%
Debt:
  • Current Ratio: 2.55%
  • Quick Ratio: 2.22%
Additional Links:
Companies Related to Enzo Biochem:

Analyst Ratings

Consensus Ratings for Enzo Biochem (NYSE:ENZ) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: N/A

Analysts' Ratings History for Enzo Biochem (NYSE:ENZ)
Show:
DateFirmActionRatingPrice TargetDetails
2/9/2016Dawson JamesReiterated RatingBuyView Rating Details
(Data available from 9/24/2014 forward)

Earnings

Earnings History for Enzo Biochem (NYSE:ENZ)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/11/2016        
6/8/2016Q316($0.06)($0.04)$24.50 million$18.16 millionViewN/AView Earnings Details
3/9/2016Q216($0.06)($0.07)$24.43 million$24.60 millionViewN/AView Earnings Details
12/7/2015Q116($0.05)($0.05)$25.20 millionViewN/AView Earnings Details
10/13/2015Q415($0.06)($0.06)$24.60 million$25.70 millionViewListenView Earnings Details
6/9/2015Q315($0.06)($0.07)$24.40 millionViewN/AView Earnings Details
3/12/2015Q215($0.09)($0.09)$23.10 millionViewN/AView Earnings Details
12/9/2014Q114($0.08)($0.08)$24.50 millionViewListenView Earnings Details
10/9/2014($0.07)($0.06)ViewListenView Earnings Details
6/9/2014Q314($0.09)($0.01)$22.80 million$24.00 millionViewN/AView Earnings Details
3/11/2014Q2($0.08)($0.09)$22.00 million$22.93 millionViewListenView Earnings Details
12/11/2013Q1($0.06)($0.07)ViewListenView Earnings Details
10/16/2013Q413($0.08)$22.00 million$23.30 millionViewListenView Earnings Details
6/10/2013Q3 2013($0.15)$22.20 million$22.60 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Enzo Biochem (NYSE:ENZ)
Current Year EPS Consensus Estimate: $-0.23 EPS
Next Year EPS Consensus Estimate: $-0.18 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.06)($0.06)($0.06)
Q3 20161($0.05)($0.05)($0.05)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Enzo Biochem (NYSE:ENZ)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Enzo Biochem (NYSE:ENZ)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for Enzo Biochem (NYSE:ENZ)
DateHeadline
publicnow.com logoEnzo Biochem Announces New York State Health Department Approval of New Easily Adaptable, Cost Effective Cardiac Assay (NYSE:ENZ)
www.publicnow.com - September 21 at 5:21 PM
openpr.com logoNonalcoholic Steatohepatitis Market: Segment and Analysis up to 2015 – 2020 (NYSE:ENZ)
www.openpr.com - September 19 at 3:43 PM
openpr.com logoBiomarkers Market to Cross US$ 50 Billion by 2021 (NYSE:ENZ)
www.openpr.com - September 15 at 5:12 PM
News IconEnzo Biochem, Inc. Pipeline Review, Market Demand, Price, and Clinical trial 2016 – 2020 (NYSE:ENZ)
www.medgadget.com - September 14 at 8:59 AM
News IconNew report shares details about the global biomarkers industry (NYSE:ENZ)
www.whatech.com - September 9 at 9:41 AM
sbwire.com logoCatharanthine Market Globally Expected to Drive Growth Through 2026 (NYSE:ENZ)
www.sbwire.com - September 9 at 9:41 AM
News IconNonalcoholic Steatohepatitis Market: Size, Share, Dynamics and Trends by 2014 – 2020 (NYSE:ENZ)
www.medgadget.com - September 7 at 8:11 AM
openpr.com logoNonalcoholic Steatohepatitis Market: Global Industry Analysis and Forecast, 2014 – 2020 (NYSE:ENZ)
www.openpr.com - September 4 at 9:17 AM
News IconCatharanthine Market Segments and Key Trends 2016-2026 (NYSE:ENZ)
reports.pr-inside.com - August 16 at 4:55 PM
investornewswire.com logoIs $8 Price Target Attainable For Enzo Biochem, Inc. (NYSE:ENZ)? - Investor Newswire (NYSE:ENZ)
www.investornewswire.com - July 25 at 10:20 PM
news.cmlviz.com logoOption Market: Enzo Biochem Inc (NYSE:ENZ) Risk Hits An Elevated Level - CML News (NYSE:ENZ)
news.cmlviz.com - July 21 at 4:59 PM
News IconEnzo Biochem Incorporated (NYSE:ENZ) Sellers Increased By 319.39% Their Shorts - Press Telegraph (NYSE:ENZ)
presstelegraph.com - July 20 at 6:07 PM
equities.com logoEnzo Biochem Inc. ($0.01 Par Value) (ENZ) Hits New 52-week High During July 18 Session - Equities.com (NYSE:ENZ)
www.equities.com - July 20 at 7:37 AM
capitalcube.com logoETF’s with exposure to Enzo Biochem, Inc. : July 19, 2016 (NYSE:ENZ)
www.capitalcube.com - July 19 at 12:20 PM
News IconWhat's in Enzo Biochem, Inc. After Today's Huge Increase? - Press Telegraph (NYSE:ENZ)
presstelegraph.com - July 15 at 11:01 AM
ftsenews.co.uk logoEnzo Biochem, Inc. (NYSE:ENZ) Updated Price Targets - FTSE News (NYSE:ENZ)
www.ftsenews.co.uk - July 15 at 11:01 AM
news.cmlviz.com logoEnzo Biochem Inc Stock Momentum Hits Strength - CML News (NYSE:ENZ)
news.cmlviz.com - July 15 at 11:01 AM
marketnewsvideo.com logoShort Interest Decreases By 30.7% For ENZ (NYSE:ENZ)
www.marketnewsvideo.com - July 14 at 8:02 AM
finance.yahoo.com logoStrength Seen in Heska (HSKA): Stock Jumps 5.7% in Session (NYSE:ENZ)
finance.yahoo.com - July 11 at 8:35 AM
finance.yahoo.com logoEnzo Biochem’s Life Sciences Unit Reaches $21 Million Patent Infringement Settlement in Delaware With Illumina, Inc. (NYSE:ENZ)
finance.yahoo.com - July 7 at 9:15 AM
biz.yahoo.com logoENZO BIOCHEM INC Files SEC form 8-K, Other Events (NYSE:ENZ)
biz.yahoo.com - June 27 at 4:50 PM
4-traders.com logoEnzo Biochem : Added To Russell 2000, Russell 3000 and Russell Global Indexes (NYSE:ENZ)
www.4-traders.com - June 27 at 4:48 PM
finance.yahoo.com logoEnzo Biochem Added To Russell 2000, Russell 3000 and Russell Global Indexes (NYSE:ENZ)
finance.yahoo.com - June 27 at 7:30 AM
realistinvestor.com logoEnzo Biochem, Inc. (NYSE:ENZ) Yearly Accounts Payable At $8.762 Millions - RealistInvestor.com (NYSE:ENZ)
www.realistinvestor.com - June 25 at 4:40 PM
investornewswire.com logoStrong Sell Calls Recommendations For Enzo Biochem, Inc. (NYSE:ENZ) At 0 - Investor Newswire (NYSE:ENZ)
www.investornewswire.com - June 25 at 4:40 PM
streetupdates.com logoAnalysts Ranking Previews: Enzo Biochem, Inc. (NYSE:ENZ) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Updates (NYSE:ENZ)
www.streetupdates.com - June 25 at 4:40 PM
finance.yahoo.com logoGlobal Osteonecrosis Pipeline Report 2016 - Therapeutics Review of Bone Therapeutics, Enzo Biochem, & K-Stemcell Co. - Research and Markets (NYSE:ENZ)
finance.yahoo.com - June 24 at 11:38 AM
finance.yahoo.com logoEdited Transcript of ENZ earnings conference call or presentation 8-Jun-16 12:30pm GMT (NYSE:ENZ)
finance.yahoo.com - June 24 at 9:55 AM
News IconTraders Are Bullish Enzo Biochem, Inc. After Today's Gap Up - Press Telegraph (NYSE:ENZ)
presstelegraph.com - June 23 at 9:54 PM
fiscalstandard.com logoEnzo Biochem, Inc. (NYSE:ENZ) Current Analyst Ratings - Fiscal Standard (NYSE:ENZ)
www.fiscalstandard.com - June 23 at 6:49 AM
news.cmlviz.com logoEnzo Biochem Inc. (NYSE:ENZ) Stock Momentum Hits Strength - CML News (NYSE:ENZ)
news.cmlviz.com - June 23 at 6:49 AM
newsmaker.com.au logoOsteonecrosis Pipeline Market Global Stage and Molecule Types (NYSE:ENZ)
www.newsmaker.com.au - June 22 at 4:58 PM
newsmaker.com.au logoOxidative Stress Assay 2016 Global Market Opportunities and Forecasts 2022 (NYSE:ENZ)
www.newsmaker.com.au - June 22 at 9:33 AM
sbwire.com logoUveitis Treatment Market - Asia to Witness Fastest Growth by 2020 (NYSE:ENZ)
www.sbwire.com - June 21 at 4:39 PM
realistinvestor.com logoEnzo Biochem, Inc. (NYSE:ENZ) Accounts Payable Is $9.152 For The Quarter Ended 2016-04-30 - RealistInvestor.com (NYSE:ENZ)
www.realistinvestor.com - June 19 at 9:13 AM
investornewswire.com logoStrong Buy Calls Count For Enzo Biochem, Inc. (NYSE:ENZ) At 1 - Investor Newswire (NYSE:ENZ)
www.investornewswire.com - June 19 at 9:13 AM
equities.com logoEnzo Biochem Inc. ($0.01 Par Value) (ENZ) Drops 5.01% on June 13 - Equities.com (NYSE:ENZ)
www.equities.com - June 15 at 9:34 AM
finance.yahoo.com logoENZO BIOCHEM INC Financials (NYSE:ENZ)
finance.yahoo.com - June 11 at 1:04 PM
equities.com logoEnzo Biochem Inc. ($0.01 Par Value) (ENZ) is Trading Higher on Unusual Volume for June 08 - Equities.com (NYSE:ENZ)
www.equities.com - June 10 at 8:21 AM
seekingalpha.com logoEnzo Biochem (ENZ) Q3 2016 Results - Earnings Call Transcript - Seeking Alpha (NYSE:ENZ)
seekingalpha.com - June 9 at 8:56 AM
equities.com logoEnzo Biochem Inc. ($0.01 Par Value) (ENZ) is Trading Lower on Unusual Volume for June 07 - Equities.com (NYSE:ENZ)
www.equities.com - June 9 at 8:56 AM
reuters.com logoBRIEF-Enzo Biochem Q3 non-gaap loss per share $0.04 - Reuters (NYSE:ENZ)
www.reuters.com - June 8 at 5:00 PM
businesswire.com logoEnzo Biochem Reports Fiscal Third Quarter Results - Business Wire (press release) (NYSE:ENZ)
www.businesswire.com - June 8 at 5:00 PM
finance.yahoo.com logoEnzo Biochem Reports Fiscal Third Quarter Results (NYSE:ENZ)
in.finance.yahoo.com - June 8 at 9:11 AM
biz.yahoo.com logoENZO BIOCHEM INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure (NYSE:ENZ)
biz.yahoo.com - June 8 at 8:01 AM
sg.finance.yahoo.com logoEnzo Biochem reports 3Q loss (NYSE:ENZ)
sg.finance.yahoo.com - June 8 at 7:43 AM
sbwire.com logoPseudomonas Diagnostic Testing Market Research Report : Forecast 2015 - 2021 (NYSE:ENZ)
www.sbwire.com - June 7 at 4:56 PM
News IconResearch focused on the osteoporosis pipeline market review 2016 (NYSE:ENZ)
www.whatech.com - June 7 at 4:56 PM
4-traders.com logoENZO BIOCHEM INC : Other Events (form 8-K) (NYSE:ENZ)
www.4-traders.com - June 7 at 4:56 PM
tmcnet.com logoEnzo Biochem Announces New York State Approval of New Women's Test Based on Proprietary Technology (NYSE:ENZ)
it.tmcnet.com - June 7 at 4:56 PM

Social

Enzo Biochem (NYSE:ENZ) Chart for Saturday, September, 24, 2016


Last Updated on 9/24/2016 by MarketBeat.com Staff